Kaohoon Online has selected stocks with a high-growth potential for investors to consider on November 15, 2022.
Finansia Syrus Securities (FSS) has given a “BUY” recommendation on CH. Karnchang Public Company Limited (SET: CK) with a target price at ฿29.00/share.
FSS stated that CK reported 3Q22 normalized earnings (+79% Q-Q, +95% Y-Y), beating its estimate and the consensus forecast by 12% due to solid growth in the profit-sharing from its associates, including BEM and CKP. Also, construction revenue recovered Q-Q and Y-Y. In 4Q22, FSS expected the profit to slow Q-Q, in line with seasonality and an absence of the dividends earned. However, FSS anticipated the 2022 earnings to jump by 4x Y-Y. Also, it would surge (+64% Y-Y) in 2023. Besides, the contract signing of the Luang Prabang project and the clarity of the Orange Line should provide catalysts.
Finansia Syrus Securities (FSS) has given a “BUY” recommendation on Bangkok Dusit Medical Services Public Company Limited (SET: BDMS) with a target price at ฿33.00/share.
The reported 3Q22 net profit (+27% Q-Q, +47% Y-Y), beating its estimate and the consensus forecast by 14-21% due to revenue from Thai patients and higher-than-expected EBITDA margin. Specifically, the 3Q22 Thai patient revenue exceeded its pre-covid level, while international patient revenue hit 94%. In 4Q22, the earnings should remain robust.
